Linaclotide

Constella

290 MCG CapsuleCanadaMarketedAuthorised 17 Dec 2014

In other countries

The same active substances on other registers, the same brand first.

Constella 290 microgramos capsulas durasSpain · 0,290 mg · cápsula dura · Abbvie Deutschland Gmbh & Co. KgSame brand
ConstellaEuropean Union · AbbVie Deutschland GmbH & Co. KGSame brand
ConstellaCroatiaSame brand
ConstellaItaly · Capsula rigida · Abbvie Deutschland GMBH & Co. KGSame brand
Constella 290 microgram harde capsulesNetherlands · Capsule, hard · AbbVie Deutschland GmbH & Co. KGSame brand
LinzessUnited States · 145MCG, 290MCG, 72MCG · capsule · AbbvieSame form
LinaclotideUnited States · 145MCG, 290MCG, 72MCG · capsule · Actavis Labs FL INCSame form

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Linaclotide

Constella

290 MCG CapsuleCanadaMarketedAuthorised 17 Dec 2014

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

LinzessSaudi Arabia · Forest Laboratories Ireland Limited

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Linaclotide
Strength: 290 MCG
Dosage form: Capsule
Route: Oral
Register: Canada (Health Canada)
Status: Marketed
Authorised: 17 Dec 2014
Registration: DIN 02417170
Marketing authorisation holder: Abbvie Corporation
ATC code: A06AX04
Group: Alimentary tract and metabolism
Supply: PRESCRIPTION